Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis
article
OA: closed
CC0
⤵ 84 in-corpus citations
AI-generated summary
Immature dendritic cells infiltrate endometriosis lesions, promoting angiogenesis and lesion growth, similar to their role in tumor development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis affects 10-15% of women and is associated with pelvic pain and infertility. Angiogenesis plays an essential role in its pathogenesis. Dendritic cells (DCs) were recently implicated in supporting tumor angiogenesis. As both tumors and endometriosis lesions depend on angiogenesis, we investigated the possibility that DCs may also play a role in endometriosis. We induced endometriosis in 8-wk-old female C57BL/6 mice by implantation of autologous endometrium into the peritoneal cavity. We observed an abundance of CD11c(+) DCs infiltrating sites of angiogenesis in endometriosis lesions. We noticed a similar pattern of infiltrating DCs at sites of angiogenesis in the peritoneal Lewis lung carcinoma tumor model. These DCs were immature (major histocompatability complex class II(low)) and expressed vascular endothelial growth factor receptor 2. Peritoneal implanted bone marrow-derived DCs (BMDCs) incorporated into both endometriosis lesions and into B16 melanoma tumors and enhanced their growth at 8 days compared with controls (5.1+/-2.5 vs. 1.5+/-0.5 mm(2), n=4 and 4, P<0.0001 for endometriosis; 67.6+/-15.1 vs. 22.7+/-14.6 mm(2), n=5 and 7, P=0.0004 for mouse melanoma). Finally, immature BMDCs but not mature BMDCs enhanced microvascular endothelial cell migration in vitro (219+/-51 vs. 93+/-32 cells, P=0.02). Based on these findings, we suggest a novel role for DCs in supporting angiogenesis and promoting lesion growth both in endometriosis and in tumors.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Angiogenic Factors in Endometriosis via openalex
- A Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
- Deficient cellular immunity in endometriosis via openalex
- Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder via openalex
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility via openalex
- Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model via openalex
- Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model via openalex
- The Epidemiology of Endometriosis via openalex
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W2102252358 via openalex
- W2125533152 via openalex
- W2132817788 via openalex
- W2137670912 via openalex
- W2140246703 via openalex
- W2793323124 via openalex
- W29925897 via openalex
- W4211081176 via openalex
- W141728048 via openalex
- W1505037806 via openalex
- W1516386979 via openalex
- W1661544713 via openalex
- W1790202563 via openalex
- W1972758309 via openalex
- W2002251604 via openalex
- W2010454841 via openalex
- W2038601735 via openalex
- W2059971077 via openalex
- W2063545389 via openalex
Cited by (50)
- Managing endometriosis and endometriosis-linked cardiovascular disease events/risks with simvastatin-loaded self-nanoemulsifying drug delivery system in humanised endometriotic SD rat model 2026
- Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review) 2024
- Investigating endometriosis development and endometriosis-related pain over time and in relation to estrogen in a laparoscopic mouse model 2024
- Causal association of immune cells and endometriosis: a Mendelian randomization study 2024
- Causal Relationship Between Endometriosis and Pelvic Inflammatory Diseases: Mendelian Randomization Study 2024
- The vicious cycle of chronic endometriosis and depression—an immunological and physiological perspective 2024
- Endometrial Receptivity in Women with Endometriosis 2024
- Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives 2023
- A novel therapeutic approach for endometriosis using adipose-derived stem cell-derived conditioned medium- A new hope for endometriotic patients in improving fertility 2023
- Similarities in Pathogenetic Mechanisms Underlying the Bidirectional Relationship between Endometriosis and Pelvic Inflammatory Disease 2023
- Features of peritoneal dendritic cells in the development of endometriosis 2023
- Understanding endometriosis from an immunomicroenvironmental perspective 2023
- Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model 2022
- Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis 2022
- The Promises of Natural Killer Cell Therapy in Endometriosis 2022
- Immunopathogenesis of endometriosis: An overview of the role of innate and adaptive immune cells and their mediators 2022
- Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications 2022
- Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis 2022
- Re-evaluation of mouse models of endometriosis for pathological and immunological research 2022
- Additional file 2 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- The role of dendritic cells in endometriosis: A systematic review 2021
- Recombinant human IL-37 inhibited endometriosis development in a mouse model through increasing Th1/Th2 ratio by inducing the maturation of dendritic cells 2021
- n-Butyl Benzyl Phthalate Exposure Promotes Lesion Survival in a Murine Endometriosis Model 2021
- Additional file 6 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 3 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 5 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 9 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 10 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 4 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 2 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 9 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 7 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Immunosuppression and immunotherapy in endometriosis 2021
- O inibidor Btk Ibrutinib limita o desenvolvimento da endometriose em camundongos 2021
- Additional file 4 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 6 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 10 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 5 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 7 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 3 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 1 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 8 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 12 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 1 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 12 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 11 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 8 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Altered immune environment in peritoneal endometriotic lesions: relationship to lesion appearance 2020
- Immunological changes associated with adenomyosis: a systematic review 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:48.452140+00:00
License: CC0
· commercial use OK